HIV Infections: all 4,340 studies

Page 11 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and AdolescentsCompletedNCT00485264Phase 1/2Results posted
• Multicenter, Safety Study Of MaravirocCompletedNCT00478231Phase 3Results posted
• Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in MenCompletedNCT00458393Phase 3Results posted
• Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/RitonavirCompletedNCT00458302Phase 3Results posted
• HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsCompletedNCT00450580Phase 3Results posted
• Botswana TDF/FTC Oral HIV Prophylaxis TrialCompletedNCT00448669Phase 2/3Results posted
• Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot EvaluationTerminatedNCT00447902Phase 3Results posted
• MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)TerminatedNCT00443729Phase 3Results posted
• MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)TerminatedNCT00443703Phase 3Results posted
• HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIVCompletedNCT00442962Phase 4Results posted
• Pioglitazone to Treat Fatty Liver in People With HIV InfectionCompletedNCT00441272Phase 2Results posted
• Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 InfectionCompletedNCT00440947Phase 3Results posted
• SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoCTerminatedNCT00440271Phase 3Results posted
• A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.CompletedNCT00435929Phase 1Results posted
• Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative VolunteersCompletedNCT00434512Phase 2Results posted
• Metabolic Effects of Non-Thymidine Analogue Anti-HIV MedicationsCompletedNCT00433992Results posted
• Optimizing Pediatric HIV-1 Treatment, Nairobi, KenyaTerminatedNCT00428116Not applicableResults posted
• Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaTerminatedNCT00427297Phase 3Results posted
• Expanded Access Program for Maraviroc At Multiple CentersCompletedNCT00426660Phase 3Results posted
• Pain and Sensory Changes Assessment in HIV+ PatientsCompletedNCT00422695Results posted
• FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous TreatmentCompletedNCT00414635Phase 4Results posted
• Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 InfectionCompletedNCT00414518Not applicableResults posted
• Metabolic Effects of Switching Kaletra to Boosted ReyatazCompletedNCT00413153Not applicableResults posted
• Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in ZimbabweCompletedNCT00390949Not applicableResults posted
• Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive AdultsCompletedNCT00389207Phase 3Results posted
• Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected AdultsCompletedNCT00376935Phase 2Results posted
• Extending HIV Care Beyond the Rural Health CenterCompletedNCT00371540Not applicableResults posted
• A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)CompletedNCT00369941Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected ChildrenCompletedNCT00364793Phase 1/2Results posted
• A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected SubjectsCompletedNCT00363142Phase 3Results posted
• Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American WomenCompletedNCT00362375Phase 1/2Results posted
• Minocycline for the Treatment of Decreased Mental Function in HIV-Infected AdultsTerminatedNCT00361257Phase 2Results posted
• Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected SubjectsCompletedNCT00358917Phase 3Results posted
• Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV TherapyCompletedNCT00357552Not applicableResults posted
• Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected SubjectsCompletedNCT00352911Phase 2Results posted
• Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral TherapyCompletedNCT00352053Phase 3Results posted
• Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)TerminatedNCT00350623Phase 2Results posted
• Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive ParticipantsCompletedNCT00350272Phase 2Results posted
• Antiretroviral Therapy for Advanced HIV Disease in South AfricaCompletedNCT00342355Phase 4Results posted
• Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic SuppressionCompletedNCT00337467Phase 3Results posted
• ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial RegimensCompletedNCT00335322Phase 4Results posted
• BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.CompletedNCT00326963Phase 4Results posted
• Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant WomenCompletedNCT00326716Phase 1Results posted
• TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily TruvadaCompletedNCT00323492Phase 4Results posted
• Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of ChloroquineTerminatedNCT00308620Phase 2/3Results posted
• Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIVCompletedNCT00307151Phase 2Results posted
• A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected SubjectsCompletedNCT00296504Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)CompletedNCT00293267Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)CompletedNCT00293254Phase 3Results posted
• Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)CompletedNCT00285584Phase 1Results posted
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose TruvadaCompletedNCT00272779Phase 3Results posted
• Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVCompletedNCT00270296Phase 2Results posted
• Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug UsersTerminatedNCT00270257Phase 3Results posted
• Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAARTCompletedNCT00270205Phase 1/2Results posted
• Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) NeuropathyCompletedNCT00264875Phase 3Results posted
• Valganciclovir to Reduce T Cell Activation in HIV InfectionCompletedNCT00264290Phase 4Results posted
• Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected SubjectsCompletedNCT00262522Phase 3Results posted
• Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African CommunitiesCompletedNCT00255840Not applicableResults posted
• Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIVCompletedNCT00244712Phase 4Results posted
• Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672)CompletedNCT00243230Phase 2Results posted
• "The Once A Day Protease Inhibitor Regimens"CompletedNCT00242216Phase 4Results posted
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-InfectionTerminatedNCT00239733Phase 4Results posted
• HIV Vaccine Trial in Thai AdultsCompletedNCT00223080Phase 3Results posted
• Viral Dynamics and Pharmacokinetics of Abacavir and TenofovirCompletedNCT00214890Phase 2Results posted
• Combination Vaccination Before HIV Treatment InterruptionCompletedNCT00212888Phase 1/2Results posted
• Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)CompletedNCT00207142Phase 4Results posted
• Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNCT00197145Phase 3Results posted
• ARVs to Prevent Breastmilk HIV:Viral and Immune ResponsesCompletedNCT00167674Phase 2Results posted
• Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaCompletedNCT00164281Phase 4Results posted
• Kaletra Sex/Gender Pharmacokinetics (PK) StudyCompletedNCT00148759Phase 4Results posted
• Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected SubjectsCompletedNCT00146328Phase 2/3Results posted
• A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to TreatmentCompletedNCT00145795Phase 4Results posted
• Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)CompletedNCT00144170Phase 3Results posted
• Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSMCompletedNCT00137631Phase 1/2Results posted
• Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative MenCompletedNCT00131677Phase 2Results posted
• A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 StudyCompletedNCT00128830Phase 2Results posted
• Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, ThailandCompletedNCT00119106Phase 2/3Results posted
• Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive AdultsCompletedNCT00118898Phase 3Results posted
• Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected SubjectsCompletedNCT00112047Phase 3Results posted
• Safety and Tolerability of PRO 140 in HIV Uninfected Male VolunteersCompletedNCT00110591Phase 1Results posted
• A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral MedicinesCompletedNCT00110305Phase 2Results posted
• Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving BirthCompletedNCT00109590Phase 2Results posted
• Anti-HIV Medications for People Recently Infected With HIVCompletedNCT00106171Phase 4Results posted
• Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)CompletedNCT00105157Phase 2Results posted
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthCompletedNCT00102960Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)CompletedNCT00100048Phase 2Results posted
• Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During PregnancyCompletedNCT00099632Phase 2Results posted
• Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV TransmissionCompletedNCT00099359Phase 3Results posted
• Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected SubjectsCompletedNCT00098748Phase 2/3Results posted
• Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected SubjectsCompletedNCT00098722Phase 2/3Results posted
• Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected SubjectsCompletedNCT00098306Phase 2/3Results posted
• Androgen Effects in HIV-infected WomenCompletedNCT00095212Not applicableResults posted
• Nine Month Course of Anti-HIV Medications for People Recently Infected With HIVTerminatedNCT00090779Phase 2Results posted
• 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV InfectionCompletedNCT00089583Phase 2Results posted
• NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV TransmissionCompletedNCT00089505Phase 3Results posted
• Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited SettingsCompletedNCT00084136Phase 4Results posted
• Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected ChildrenCompletedNCT00076999Phase 1Results posted
• Helping HIV Infected Patients in South Africa Adhere to Drug RegimensTerminatedNCT00076804Phase 2Results posted
• Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedNCT00074581Phase 3Results posted
• Using Nevirapine to Prevent Mother-to-Child HIV Transmission During BreastfeedingCompletedNCT00074412Phase 3Results posted

← HIV Infections overview